Cotinga Pharmaceuticals Inc. (COTQF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2018 | -1.92 Million USD | 59.64% |
| 2017 | -6.05 Million USD | 4.78% |
| 2016 | -5.95 Million USD | -63.99% |
| 2015 | -3.84 Million USD | -8.97% |
| 2014 | -3.15 Million USD | -21.9% |
| 2013 | -2.44 Million USD | -6.3% |
| 2012 | -2.1 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2019 Q2 | -360.00 USD | 3.2% |
| 2019 Q3 | -343.36 USD | 4.62% |
| 2019 Q1 | -371.90 USD | 29.71% |
| 2018 Q4 | -529.11 USD | -111.68% |
| 2018 FY | - USD | 59.64% |
| 2018 Q1 | -680.48 USD | 43.81% |
| 2018 Q2 | -395.93 USD | 41.82% |
| 2018 Q3 | -249.95 USD | 36.87% |
| 2017 Q3 | -1099.36 USD | 17.42% |
| 2017 Q2 | -1331.25 USD | -13.74% |
| 2017 Q1 | -1170.41 USD | 11.03% |
| 2017 FY | - USD | 4.78% |
| 2017 Q4 | -1211.01 USD | -10.16% |
| 2016 Q4 | -1315.59 USD | 13.69% |
| 2016 Q3 | -1524.32 USD | -21.72% |
| 2016 FY | - USD | -63.99% |
| 2016 Q2 | -1252.31 USD | -28.06% |
| 2016 Q1 | -977.93 USD | -15.52% |
| 2015 FY | - USD | -8.97% |
| 2015 Q4 | -846.51 USD | -29.18% |
| 2015 Q3 | -655.28 USD | 7.59% |
| 2015 Q2 | -709.08 USD | -12.42% |
| 2015 Q1 | -630.76 USD | 17.84% |
| 2014 FY | - USD | -21.9% |
| 2014 Q3 | -669.32 USD | 4.46% |
| 2014 Q2 | -700.57 USD | 6.81% |
| 2014 Q1 | -751.76 USD | 27.83% |
| 2014 Q4 | -767.74 USD | -14.7% |
| 2013 Q4 | -1041.64 USD | -114.62% |
| 2013 FY | - USD | -6.3% |
| 2013 Q2 | -446.30 USD | -24.76% |
| 2013 Q1 | -357.73 USD | 8.24% |
| 2013 Q3 | -485.34 USD | -8.75% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | -389.85 USD | 29.02% |
| 2012 Q2 | -632.89 USD | 0.0% |
| 2012 Q3 | -549.25 USD | 13.22% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 97.296% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 67.601% |
| SQZ Biotechnologies Company | -64.14 Million USD | 97.005% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 88.941% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 102.043% |
| Mesoblast Limited | -62.38 Million USD | 96.921% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -25.055% |
| Genus plc | 73.7 Million USD | 102.606% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 70.946% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 45.844% |
| Marizyme, Inc. | -34.28 Million USD | 94.397% |
| ContraFect Corporation | -64.99 Million USD | 97.045% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 78.102% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 57.56% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -37.031% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 27.361% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 17.338% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -270.799% |
| Accustem Sciences Inc. | -3.74 Million USD | 48.727% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 96.017% |
| EV Biologics, Inc. | -1.26 Million USD | -51.595% |
| Q BioMed Inc. | -617.62 Thousand USD | -211.014% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 153.777% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -203.746% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 15.915% |
| Biomind Labs Inc. | -1.03 Million USD | -85.676% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 119.448% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 73.176% |
| Skye Bioscience, Inc. | -13.54 Million USD | 85.821% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -29.145% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -7583.644% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 50.547% |
| IMV Inc. | -35.52 Million USD | 94.593% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 87.896% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 23.224% |
| GB Sciences, Inc. | -1.41 Million USD | -35.286% |
| Alpha Cognition Inc. | -9.7 Million USD | 80.208% |
| HST Global, Inc. | -5303.00 USD | -36123.1% |
| CSL Limited | 4.78 Billion USD | 100.04% |
| Halberd Corporation | -74.27 Thousand USD | -2486.075% |
| Enzolytics Inc. | -2.12 Million USD | 9.478% |
| Resverlogix Corp. | -11.74 Million USD | 83.641% |
| Affymax, Inc. | -14.29 Million USD | 86.562% |
| SYBLEU INC | -141.57 Thousand USD | -1256.853% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 37.287% |
| argenx SE | -216.02 Million USD | 99.111% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 96.529% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 257.84% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -28.154% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 607.045% |
| AVAX Technologies, Inc. | -6.11 Million USD | 68.575% |
| Zenith Capital Corp. | -8.6 Million USD | 77.679% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.228% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -10926.411% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 21.482% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -991.276% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 95.154% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 33.586% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -83.589% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 28667.98% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -9.766% |
| BioStem Technologies, Inc. | -7.55 Million USD | 74.57% |
| ONE Bio Corp. | 13.61 Million USD | 114.111% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -960.761% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 6.616% |
| Agentix Corp. | -1.37 Million USD | -40.033% |
| LadRx Corporation | 412.28 Thousand USD | 565.92% |
| Cell Source, Inc. | -4.27 Million USD | 55.04% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -423.094% |
| Regen BioPharma, Inc. | 1.46 Million USD | 231.035% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -105.018% |
| NovAccess Global Inc. | -1.03 Million USD | -85.632% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 121.696% |
| Itoco Inc. | -1.86 Million USD | -2.778% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -406.009% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -72.125% |
| Kadimastem Ltd | -2.62 Million USD | 26.805% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -703.224% |
| CytoDyn Inc. | -18.02 Million USD | 89.345% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -2330.641% |
| Mobile Lads Corp. | -2.24 Million USD | 14.289% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -15607.834% |
| Qrons Inc. | -40.08 Thousand USD | -4692.573% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -295.511% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 464.2% |
| Rebus Holdings, Inc. | -951 Thousand USD | -101.989% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -80.875% |
| International Stem Cell Corporation | 202 Thousand USD | 1050.946% |
| Bioxytran, Inc. | -3.82 Million USD | 49.716% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -3549.147% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 21.975% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 94.645% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -4168.691% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 29.843% |
| Neutra Corp. | -181.24 Thousand USD | -959.831% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 90.471% |
| PureTech Health plc | -11.62 Million USD | 83.479% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 90.471% |
| IXICO plc | -707 Thousand USD | -171.699% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 75.004% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 96.027% |
| CSL Limited | 4.73 Billion USD | 100.041% |
| Cellectis S.A. | -92.63 Million USD | 97.926% |